Literature DB >> 18773337

Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.

Koichi Nishimura1, Toru Oga, Akihiko Ikeda, Takashi Hajiro, Mitsuhiro Tsukino, Hiroshi Koyama.   

Abstract

Three methods have been developed to measure health-related quality of life (HRQoL) expressed as a single value: the global rating scale, the total score obtained from disease-specific instruments, and the preference-based utility index. We compared these different single HRQoL measurements in patients with asthma and chronic obstructive pulmonary disease (COPD). We recruited 167 patients with asthma and 161 patients with COPD. The global rating HRQoL was assessed by the Hyland scale. The total HRQoL was assessed by the Living With Asthma Questionnaire in asthma and the St. George's Respiratory Questionnaire in COPD. The Quality of Well-being (QWB) scale was used for the utility measurement derived from the Medical Outcome Study Short-form 36. The inter-relationships between these three HRQoL values were weak to moderate in asthma and moderate in COPD. In asthma, the Hyland scale was weakly correlated with the total HRQoL (Spearman's rank correlation coefficients [Rs] = -0.20) and moderately with the QWB score (Rs = -0.43). In the stepwise multiple regression analyses, anxiety on the Hospital Anxiety and Depression scale and the dyspnea score tended to correlate more significantly with the single HRQoL values in both asthma and COPD than physiological measurements such as the forced expiratory volume in one second. The Hyland scale was less correlated with existing parameters (cumulative coefficient determination [R(2)] = 0.04) than the total HRQoL (cumulative R(2) = 0.47) and the QWB scale (cumulative R(2) = 0.49) in asthma. The single HRQoL values from the Hyland scale, the total HRQoL and the QWB scale evaluated different aspects of asthma and COPD. The psychological status and dyspnea contributed more significantly to the single HRQoL values in these two disorders than the physiological measurements. In asthma, the Hyland scale was especially different from the other single HRQoL scales and should be evaluated separately from the multi-item HRQoL assessments.

Entities:  

Mesh:

Year:  2008        PMID: 18773337     DOI: 10.1080/02770900802127014

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  12 in total

Review 1.  Asthma outcomes: quality of life.

Authors:  Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Jonathan D Campbell; Gary Globe; Bruce Bender; David J Magid
Journal:  Qual Life Res       Date:  2016-07-07       Impact factor: 4.147

3.  Subjective ratings of prolonged inspiratory resistive loaded breathing in males and females.

Authors:  Sarah Miller; Paul W Davenport
Journal:  Psychophysiology       Date:  2014-09-05       Impact factor: 4.016

4.  Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD.

Authors:  Witold Mazur; Henna Kupiainen; Janne Pitkäniemi; Maritta Kilpeläinen; Harri Sintonen; Ari Lindqvist; Vuokko L Kinnula; Tarja Laitinen
Journal:  Health Qual Life Outcomes       Date:  2011-01-16       Impact factor: 3.186

5.  Validation of the Japanese version of the Sarcoidosis Health Questionnaire: a cross-sectional study.

Authors:  Kiminobu Tanizawa; Tomohiro Handa; Sonoko Nagai; Toru Oga; Takeshi Kubo; Yutaka Ito; Kizuku Watanabe; Kensaku Aihara; Kazuo Chin; Michiaki Mishima; Takateru Izumi
Journal:  Health Qual Life Outcomes       Date:  2011-05-14       Impact factor: 3.186

6.  Reliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosis.

Authors:  Abebaw M Yohannes; Mary Dodd; Julie Morris; Kevin Webb
Journal:  Health Qual Life Outcomes       Date:  2011-11-25       Impact factor: 3.186

7.  The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.

Authors:  Sokai Akihiko; Handa Tomohiro; Oga Toru; Tanizawa Kiminobu; Ikezoe Kohei; Nakatsuka Yoshinari; Kubo Takeshi; Kanatani Kumiko; Chin Kazuo; Mishima Michiaki
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 8.  Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review.

Authors:  Xinyu Qian; Rachel Lee-Yin Tan; Ling-Hsiang Chuang; Nan Luo
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

9.  Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?

Authors:  Masaaki Kusunose; Toru Oga; Saya Nakamura; Yoshinori Hasegawa; Koichi Nishimura
Journal:  BMJ Open Respir Res       Date:  2017-07-03

10.  Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Koichi Nishimura; Saya Nakamura; Masaaki Kusunose; Kazuhito Nakayasu; Ryo Sanda; Yoshinori Hasegawa; Toru Oga
Journal:  BMJ Open Respir Res       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.